Document is current
Any future updates will be listed below
-
Authors
Bouras, Marwan
Roquilly, Antoine
Mahé, Pierre-Joachim
Cinotti, Raphaël
Vourc’h, Mickaël
Perrot, Bastien
Bach-Ngohou, Kalyane
Masson, Damien
Asehnoune, Karim http://orcid.org/0000-0003-1899-3517
-
Funding
Funding for this research was provided by:
The French Society of Anesthesiology and Intensive care (SFAR) and institutional funds (.)
-
License Information
Text and Data Mining valid from 2019-12-01
Version of Record valid from 2019-12-05
-
More Information
Article History
Received: 16 July 2019
Accepted: 20 November 2019
First Online: 5 December 2019
Ethics approval and consent to participate
: This study is a sub-study of the Corti-TC trial (NCT 01093261). For the RCT trial, the independent Data and Safety Monitoring Board (DSMB) looked over the ethics in accordance with the Declaration of Helsinki, monitors patient safety, and reviews safety issues as the study progresses. Serious adverse events and unexpected related or possibly related serious events were reported blinded to the DSMB within respectively 24 h or 7 days.
: Written informed consent for publication was obtained.
: The authors declare that they have no competing interests. KA declares personal fees from LSB, Fresenius and Baxter, outside the submitted work. MV declares personal fees from MSD, Pfizer, Baxter, Grants from Fisher Paykel, outside the submitted work. AR declares personal fees from Biomerieux and MSD, outside the submitted work.
